DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Innopran XL (Propranolol Hydrochloride) - Summary

 

-- advertisement --

BOX WARNING

Angina Pectoris: There have been reports of exacerbation of angina and, in some cases, myocardial infarction, following abrupt discontinuance of propranolol therapy. Therefore, when discontinuance of propranolol is planned, the dosage should be gradually reduced over at least a few weeks, and the patient should be cautioned against interruption or cessation of therapy without a physician’s advice. If propranolol therapy is interrupted and exacerbation of angina occurs, it is usually advisable to reinstitute propranolol therapy and take other measures appropriate for the management of angina pectoris. Since coronary artery disease may be unrecognized, it may be prudent to follow the above advice in patients considered at risk of having occult atherosclerotic heart disease who are given propranolol for other indications.

 

INNOPRAN XL SUMMARY

InnoPran XL®(propranolol hydrochloride) Extended Release Capsules

InnoPran XL (propranolol hydrochloride) is a nonselective, beta-adrenergic receptor-blocking agent for oral administration, available as an extended release product.

InnoPran XL is indicated in the management of hypertension; it may be used alone or in combination with other antihypertensive agents.

INNOPRAN XL NEWS HIGHLIGHTS

Media Articles Related to Innopran XL (Propranolol)

Pseudotumor Cerebri (Idiopathic Intracranial Hypertension)
Source: MedicineNet Brain Tumor Specialty [2008.09.30]

Study Finds Antioxidant Deficiency Linked To Pulmonary Hypertension
Source: Hypertension News From Medical News Today [2008.09.24]

Vitamin C Might Help Lower Hypertension
Source: MedicineNet High Blood Pressure Specialty [2008.09.22]

Using Honeybee Venom Toxin To Develop A New Tool For Studying Hypertension
Source: Hypertension News From Medical News Today [2008.09.19]

Prehypertension by Age 35 Clogs Arteries
Source: MedicineNet CAT Scan Specialty [2008.07.15]

more>>

Published Studies Related to Innopran XL (Propranolol)

A comparison between the effect of oxytocin only and oxytocin plus propranolol on the labor (a double blind randomized trial). [2008.06]

Irbesartan plus low-dose propranolol versus low-dose propranolol alone in cirrhosis: a placebo-controlled, double-blind study. [2008.05]

Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder. [2008.05]

Hemodynamic effects of propranolol with spironolactone in patients with variceal bleeds: A randomized controlled trial. [2008.03.28]

Octreotide enhances portal pressure reduction induced by propranolol in cirrhosis: a randomized, controlled trial. [2007.10]

more>>

Clinical Trials Related to Innopran XL (Propranolol)

Effect of Prophylaxy of Amiodarone and Propranolol and Amiodarone With Propranolol in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft [Completed]

Bioavailability Study of Propranolol Under Fasting Conditions [Completed]

Bioavailability Study of Propranolol Under Fed Conditions [Completed]

Propranolol Administration and Prevention of Child PTSD in Child Trauma Victims [Completed]

Hemodynamic Effects of Chronic Administration of Spironolactone and/or Propranolol in Alcoholic Cirrhotic Patients [Terminated]

more>>

Page last updated: 2008-09-30

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008